Abstract
Objective: The therapeutic effect of magnetic resonance-guided focused ultrasound is limited to patients with low skull density ratio (SDR). We explored the skull conditions associated with successful treatment among low-SDR patients, and then, to compensate the small sample size, added analyses using all cases irrespective of SDR. This is the first report to examine the significance of the regional skull conditions. Methods: We retrospectively analyzed 171 consecutive cases. Descriptive statistics for the entire skull, along with averages for ten regions, were obtained for variables including SDR, skull thickness, and ultrasound incidence angle (IA; the smaller, the more vertical). The 1,024 ultrasonic transducer elements were divided into ten regions as predefined by ExAblate4000. Successful treatment was defined as <half preoperative symptom score at 6 months postoperatively. First, univariate analysis of cases with SDR < 0.40 was conducted to explore candidates for skull conditions associated with successful treatment. Subsequently, for all cases regardless of SDR, several multiple regression models were built to predict the maximum temperature rise, and their performance was compared. Results: Of the cohort, 26 had SDR < 0.40, and 15 were successful. Among the cases with SDR < 0.40, IA of the parietal region of the sonication side and SDR of the bilateral temporal region tended to be smaller in the success group (not statistically significant). The maximum temperature was more accurately predicted when IA of the parietal region of the sonication side was included in the model (Akaike information criterion 777 from 757). Furthermore, replacing SDR with SDR without the bilateral temporal region enhanced prediction (Akaike information criterion 777 from 767). Conclusions: Even if SDR is low, treatment success may be more attainable if the IA at the parietal region of the sonication side is smaller or if the SDR excluding the bilateral temporal regions is large.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of Hamamatsu University School of Medicine
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos